Selpercatinib is a special type of medicine that targets the RET protein. It’s used to treat certain kinds of lung cancer, thyroid cancer, and other tumors with RET changes. It’s a kinase inhibitor, which means it stops the RET protein from doing its thing.
The recommended dose for Selpercatinib is 160 mg twice daily, with or without food, and it is available in capsules of 40 mg or 80 mg strength. Each bottle comes with 60 capsules.
